vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Loar Holdings Inc. (LOAR). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $131.8M, roughly 1.6× Loar Holdings Inc.). Loar Holdings Inc. runs the higher net margin — 9.5% vs 2.7%, a 6.8% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 19.3%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 19.8%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

IRTC vs LOAR — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.6× larger
IRTC
$208.9M
$131.8M
LOAR
Growing faster (revenue YoY)
IRTC
IRTC
+7.8% gap
IRTC
27.1%
19.3%
LOAR
Higher net margin
LOAR
LOAR
6.8% more per $
LOAR
9.5%
2.7%
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
19.8%
LOAR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRTC
IRTC
LOAR
LOAR
Revenue
$208.9M
$131.8M
Net Profit
$5.6M
$12.5M
Gross Margin
70.9%
52.1%
Operating Margin
1.1%
18.0%
Net Margin
2.7%
9.5%
Revenue YoY
27.1%
19.3%
Net Profit YoY
518.5%
239.5%
EPS (diluted)
$0.18
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
LOAR
LOAR
Q4 25
$208.9M
$131.8M
Q3 25
$192.9M
$126.8M
Q2 25
$186.7M
$123.1M
Q1 25
$158.7M
$114.7M
Q4 24
$164.3M
$110.4M
Q3 24
$147.5M
$103.5M
Q2 24
$148.0M
$97.0M
Q1 24
$131.9M
$91.8M
Net Profit
IRTC
IRTC
LOAR
LOAR
Q4 25
$5.6M
$12.5M
Q3 25
$-5.2M
$27.6M
Q2 25
$-14.2M
$16.7M
Q1 25
$-30.7M
$15.3M
Q4 24
$-1.3M
$3.7M
Q3 24
$-46.2M
$8.7M
Q2 24
$-20.1M
$7.6M
Q1 24
$-45.7M
$2.2M
Gross Margin
IRTC
IRTC
LOAR
LOAR
Q4 25
70.9%
52.1%
Q3 25
71.1%
52.7%
Q2 25
71.2%
53.8%
Q1 25
68.8%
52.1%
Q4 24
70.0%
48.9%
Q3 24
68.8%
51.1%
Q2 24
69.9%
49.0%
Q1 24
66.3%
48.4%
Operating Margin
IRTC
IRTC
LOAR
LOAR
Q4 25
1.1%
18.0%
Q3 25
-4.4%
22.9%
Q2 25
-10.0%
22.2%
Q1 25
-20.5%
22.8%
Q4 24
-2.5%
19.2%
Q3 24
-34.1%
22.1%
Q2 24
-15.5%
22.9%
Q1 24
-28.9%
23.3%
Net Margin
IRTC
IRTC
LOAR
LOAR
Q4 25
2.7%
9.5%
Q3 25
-2.7%
21.8%
Q2 25
-7.6%
13.6%
Q1 25
-19.3%
13.4%
Q4 24
-0.8%
3.3%
Q3 24
-31.3%
8.4%
Q2 24
-13.6%
7.9%
Q1 24
-34.6%
2.4%
EPS (diluted)
IRTC
IRTC
LOAR
LOAR
Q4 25
$0.18
$0.13
Q3 25
$-0.16
$0.29
Q2 25
$-0.44
$0.17
Q1 25
$-0.97
$0.16
Q4 24
$-0.03
$-11023.48
Q3 24
$-1.48
$0.09
Q2 24
$-0.65
$0.09
Q1 24
$-1.47
$11023.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
LOAR
LOAR
Cash + ST InvestmentsLiquidity on hand
$583.8M
$84.8M
Total DebtLower is stronger
$715.7M
Stockholders' EquityBook value
$152.7M
$1.2B
Total Assets
$1.0B
$2.0B
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
LOAR
LOAR
Q4 25
$583.8M
$84.8M
Q3 25
$565.2M
$99.0M
Q2 25
$545.5M
$103.3M
Q1 25
$520.6M
$80.5M
Q4 24
$535.6M
$54.1M
Q3 24
$522.0M
$55.2M
Q2 24
$561.5M
$73.2M
Q1 24
$569.1M
$28.2M
Total Debt
IRTC
IRTC
LOAR
LOAR
Q4 25
$715.7M
Q3 25
$279.4M
Q2 25
$277.7M
Q1 25
$277.5M
Q4 24
$277.3M
Q3 24
$602.1M
Q2 24
$250.7M
Q1 24
$534.2M
Stockholders' Equity
IRTC
IRTC
LOAR
LOAR
Q4 25
$152.7M
$1.2B
Q3 25
$121.9M
$1.2B
Q2 25
$103.7M
$1.1B
Q1 25
$86.7M
$1.1B
Q4 24
$90.9M
$1.1B
Q3 24
$71.8M
$769.8M
Q2 24
$99.2M
$758.4M
Q1 24
$90.3M
$420.6M
Total Assets
IRTC
IRTC
LOAR
LOAR
Q4 25
$1.0B
$2.0B
Q3 25
$995.2M
$1.5B
Q2 25
$964.0M
$1.5B
Q1 25
$926.1M
$1.5B
Q4 24
$931.4M
$1.5B
Q3 24
$909.7M
$1.5B
Q2 24
$919.2M
$1.1B
Q1 24
$909.8M
$1.1B
Debt / Equity
IRTC
IRTC
LOAR
LOAR
Q4 25
0.61×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.25×
Q4 24
0.25×
Q3 24
0.78×
Q2 24
0.33×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
LOAR
LOAR
Operating Cash FlowLast quarter
$26.2M
$30.4M
Free Cash FlowOCF − Capex
$14.5M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
4.70×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
LOAR
LOAR
Q4 25
$26.2M
$30.4M
Q3 25
$34.9M
$29.7M
Q2 25
$27.7M
$23.8M
Q1 25
$-7.9M
$28.4M
Q4 24
$19.2M
$20.7M
Q3 24
$24.3M
$16.3M
Q2 24
$11.8M
$7.1M
Q1 24
$-52.0M
$10.8M
Free Cash Flow
IRTC
IRTC
LOAR
LOAR
Q4 25
$14.5M
Q3 25
$20.1M
Q2 25
$17.3M
Q1 25
$-17.3M
Q4 24
$12.4M
Q3 24
$15.5M
Q2 24
$3.4M
Q1 24
$-61.8M
FCF Margin
IRTC
IRTC
LOAR
LOAR
Q4 25
6.9%
Q3 25
10.4%
Q2 25
9.3%
Q1 25
-10.9%
Q4 24
7.5%
Q3 24
10.5%
Q2 24
2.3%
Q1 24
-46.8%
Capex Intensity
IRTC
IRTC
LOAR
LOAR
Q4 25
5.6%
Q3 25
7.7%
Q2 25
5.6%
Q1 25
5.9%
Q4 24
4.2%
Q3 24
6.0%
Q2 24
5.7%
Q1 24
7.4%
Cash Conversion
IRTC
IRTC
LOAR
LOAR
Q4 25
4.70×
2.43×
Q3 25
1.08×
Q2 25
1.42×
Q1 25
1.85×
Q4 24
5.62×
Q3 24
1.89×
Q2 24
0.93×
Q1 24
4.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

LOAR
LOAR

Other$76.8M58%
Commercial Aerospace$21.2M16%
Business Jet And General Aviation$17.6M13%
Defense$16.2M12%

Related Comparisons